Cardiovascular Diseases
Global cardiovascular disease death rates, country rankings, and trends from 1990 to 2023.
| # | Country | Rate | Region |
|---|
This page presents age-standardized cardiovascular disease death rates across 204 countries and territories, drawing on data from the IHME Global Burden of Disease Study 2024. Cardiovascular Diseases mortality patterns vary considerably by geography, income level, and access to healthcare services. Understanding the epidemiology and population-level burden of cardiovascular diseases is critical for global public health policy, disease prevention strategies, and healthcare resource allocation.
The trend chart above shows how the global cardiovascular diseases rate has evolved since 1990, reflecting changes in risk factor prevalence, diagnostic capacity, treatment availability, and demographic transitions. Country rankings provide a comparative view of the current burden, highlighting disparities between high-income and low-income nations in cardiovascular diseases outcomes.
Cardiovascular diseases (CVDs) — encompassing ischaemic heart disease, stroke, hypertensive heart disease, cardiomyopathy, atrial fibrillation, aortic aneurysm, peripheral arterial disease, and rheumatic heart disease — collectively constitute the world's leading cause of death, responsible for approximately 17.9 million fatalities annually, or roughly 32% of all global deaths. Ischaemic heart disease alone accounts for about 9 million deaths per year, driven by atherosclerotic plaque rupture, coronary thrombosis, and myocardial infarction. Stroke — both ischaemic and haemorrhagic — adds another 7 million. The pathophysiology centres on atherosclerosis, a decades-long inflammatory process in which lipid accumulation, endothelial dysfunction, and immune activation progressively narrow and destabilise arterial walls. Major modifiable risk factors include hypertension, dyslipidaemia, diabetes mellitus, tobacco use, physical inactivity, unhealthy diet, and obesity. While age-standardised CVD death rates have declined by over 30% in high-income countries since 1990 due to improved prevention and acute care, absolute CVD deaths continue to rise globally as populations age and metabolic risk factors increase in low- and middle-income countries.
CVD prevention operates at population and individual levels. Population strategies include tobacco taxation, trans-fat elimination, sodium reduction in processed foods, and urban planning that promotes physical activity. Individual-level prevention centres on blood pressure control (targeting <130/80 mmHg), statin therapy for elevated LDL cholesterol, glycaemic management in diabetes, aspirin for secondary prevention, and lifestyle modification. Acute interventions — percutaneous coronary intervention, thrombolysis for stroke, and implantable defibrillators — have dramatically improved survival from acute cardiovascular events in settings with access to advanced care.